We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
476
News Corp Class A
NWSA
$16B
| $1.59K | ﹤0.01% |
+64
| New | +$1.66K |
2026 Q2
0 quarters
|
|
477
Aspen Aerogels
ASPN
$417M
| $1.58K | ﹤0.01% |
250
| – | – |
2020 Q3
23 quarters
|
|
478
BP
BP
$124B
| $1.56K | ﹤0.01% |
+42
| New | +$1.84K |
2026 Q2
0 quarters
|
|
479
Sphere Entertainment
SPHR
$3.92B
| $1.56K | ﹤0.01% |
9
| – | – |
2023 Q4
10 quarters
|
|
480
DXC Technology
DXC
$2.31B
| $1.55K | ﹤0.01% |
175
| – | – |
2020 Q2
24 quarters
|
|
481
JBS N.V.
JBS
$40.9B
| $1.53K | ﹤0.01% |
129
+8
| +7% | +$117 |
2026 Q1
1 quarter
|
|
482
Take-Two Interactive
TTWO
$36.5B
| $1.5K | ﹤0.01% |
6
| – | – |
2020 Q1
25 quarters
|
|
483
Dow Inc
DOW
$24.9B
| $1.43K | ﹤0.01% |
52
| – | – |
2019 Q4
26 quarters
|
|
484
DNOW Inc
DNOW
$2.96B
| $1.43K | ﹤0.01% |
110
| – | – |
2024 Q2
8 quarters
|
|
485
Versigent PLC
VGNT
$3B
| $1.39K | ﹤0.01% |
+33
| New | +$1.32K |
2026 Q2
0 quarters
|
|
486
Sunbelt Rentals Holdings
SUNB
$34.9B
| $1.35K | ﹤0.01% |
18
-25
| -58% | -$1.88K |
2026 Q1
1 quarter
|
|
487
Korea Electric Power
KEP
$13.7B
| $1.21K | ﹤0.01% |
100
| – | – |
2020 Q3
23 quarters
|
|
|
TRLV
488
Trulieve Cannabis Corp
TRLV
$2.17B
| $1.18K | ﹤0.01% |
+120
| New | +$1.16K |
2026 Q2
0 quarters
|
|
489
Evolv Technologies
EVLV
$860M
| $1.16K | ﹤0.01% |
+200
| New | +$1.25K |
2026 Q2
0 quarters
|
|
490
iShares US Basic Materials ETF
IYM
$1.29B
| $1.12K | ﹤0.01% |
6
| – | – |
2023 Q3
11 quarters
|
|
491
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
| $1.12K | ﹤0.01% |
7
| – | – |
2021 Q2
20 quarters
|
|
492
Peloton Interactive
PTON
$2.32B
| $1.12K | ﹤0.01% |
190
| – | – |
2021 Q4
18 quarters
|
|
493
Ferrari
RACE
$70.5B
| $1.12K | ﹤0.01% |
+3
| New | +$1.04K |
2026 Q2
0 quarters
|
|
494
ArcelorMittal
MT
$46.9B
| $1.11K | ﹤0.01% |
18
-18
| -50% | -$1.13K |
2024 Q4
6 quarters
|
|
495
Amphastar Pharmaceuticals
AMPH
$1.15B
| $1.11K | ﹤0.01% |
55
| – | – |
2025 Q2
4 quarters
|
|
496
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.18B
| $1.11K | ﹤0.01% |
51
+1
| +2% | +$22 |
2025 Q2
4 quarters
|
|
497
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.6B
| $1.09K | ﹤0.01% |
5
+4
| +400% | +$930 |
2026 Q1
1 quarter
|
|
498
Fidelity Solana Fund
FSOL
$121M
| $1.08K | ﹤0.01% |
125
+2
| +2% | +$19 |
2025 Q4
2 quarters
|
|
499
Aon
AON
$69.7B
| $1.05K | ﹤0.01% |
3
-4
| -57% | -$1.29K |
2022 Q3
15 quarters
|
|
500
Schwab US TIPS ETF
SCHP
$17.4B
| $1.02K | ﹤0.01% |
38
| – | – |
2025 Q2
4 quarters
|
|
Similar funds
BOC
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.